MURF

NASDAQ

Murphy Canyon Acquisition Corp.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2022

$17.48-0.27 (-1.52%)

News25/Ratings0

Murphy Canyon Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying businesses in the real estate industry, including construction, homebuilding, real estate owners and operators, arrangers of financing, insurance, and other services for real estate, and adjacent businesses and technologies targeting the real estate space. The company was incorporated in 2021 and is based in San Diego, California.

Latest news

25 items

803d13D/G
SEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)
SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
807d13D/G
SEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)
SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
813d13D/G
SEC Form SC 13G/A filed by Murphy Canyon Acquisition Corp. (Amendment)
SC 13G/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
836dSEC
SEC Form S-8 filed by Murphy Canyon Acquisition Corp.
S-8 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
859dSEC
SEC Form 424B3 filed by Murphy Canyon Acquisition Corp.
424B3 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
860dSEC
SEC Form EFFECT filed by Murphy Canyon Acquisition Corp.
EFFECT - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
863dINSIDER
SEC Form 4 filed by Lewis-Hall Freda C
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
872dINSIDER
SEC Form 4 filed by Mcnealey Jennifer Isacoff
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
872dINSIDER
SEC Form 4 filed by Bligh James
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
872dINSIDER
SEC Form 4 filed by Farley Chele Chiavacci
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
872dINSIDER
SEC Form 4 filed by Charles Faith L.
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
872dINSIDER
Sragovicz Adam was granted 74,545 units of Restricted Stock Units (SEC Form 4)
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
872dINSIDER
SEC Form 4 filed by Tapolczay David
4 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Issuer)
876dSEC
SEC Form S-8 filed by Murphy Canyon Acquisition Corp.
S-8 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
876dSEC
SEC Form S-1/A filed by Murphy Canyon Acquisition Corp. (Amendment)
S-1/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
887dSEC
SEC Form 10-Q/A filed by Murphy Canyon Acquisition Corp. (Amendment)
10-Q/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
887dSEC
SEC Form 10-Q filed by Murphy Canyon Acquisition Corp.
10-Q - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
893dSEC
SEC Form NT 10-Q filed by Murphy Canyon Acquisition Corp.
NT 10-Q - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
921dSEC
SEC Form S-1 filed by Murphy Canyon Acquisition Corp.
S-1 - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
933dSEC
Murphy Canyon Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Amendments to the Registrant's Code of Ethics, or Waiver of a P
8-K/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)
936d13D/G
SEC Form SC 13G filed by Murphy Canyon Acquisition Corp.
SC 13G - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
939d13D/G
SEC Form SC 13D/A filed by Murphy Canyon Acquisition Corp. (Amendment)
SC 13D/A - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
939d13D/G
SEC Form SC 13D filed by Murphy Canyon Acquisition Corp.
SC 13D - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
939d13D/G
SEC Form SC 13G filed by Murphy Canyon Acquisition Corp.
SC 13G - CONDUIT PHARMACEUTICALS INC. (0001896212) (Subject)
940dSEC
Murphy Canyon Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Completion of Acquisition or Disposition of Assets, Change in Shell Company Status, Financial Statements and Exhibits, Unregistered Sales of Equity Securities, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Changes in Control of Registrant, Amendments to the Registrant's Code of Ethics, or Waiver of a P
8-K - CONDUIT PHARMACEUTICALS INC. (0001896212) (Filer)